For best results, take consistently
In the UK, certain GLP-1 receptor agonists (Wegovy and Saxenda) are licensed for weight management in adults without diabetes who have a BMI 30 kg/m or 27 kg/m with weight-related comorbidities
The primary bioactive compounds found in gotu kola are pentacyclic triterpenoid saponins, collectively known as centelloids
contraindicated in pregnancy due to teratogenicity risk Naltrexone-bupropion (Contrave): Opioid antagonist and antidepressant combination producing 5-6% weight loss
Challenges and Considerations While there are plenty of opportunities for beverage brands to enter the GLP-1 companion market, you should also understand the challenges
Patients who qualify for both Medi-Cal coverage and compounded therapy can also explore tirzepatide (a dual GIP/GLP-1 receptor agonist) through PlexusDx, available as a compounded injection at $289/mo month-to-month, or from $249/mo on the 6-month plan or an oral formulation at $349 monthly